CRIS
Price
$1.68
Change
-$0.03 (-1.75%)
Updated
Sep 5 closing price
Capitalization
21M
OBIO
Price
$2.75
Change
+$0.01 (+0.36%)
Updated
Sep 5 closing price
Capitalization
148.38M
Interact to see
Advertisement

CRIS vs OBIO

Header iconCRIS vs OBIO Comparison
Open Charts CRIS vs OBIOBanner chart's image
Curis
Price$1.68
Change-$0.03 (-1.75%)
Volume$65.72K
Capitalization21M
Orchestra BioMed Holdings
Price$2.75
Change+$0.01 (+0.36%)
Volume$209.96K
Capitalization148.38M
CRIS vs OBIO Comparison Chart in %
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. OBIO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and OBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRIS: $1.68 vs. OBIO: $2.75)
Brand notoriety: CRIS and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 55% vs. OBIO: 79%
Market capitalization -- CRIS: $21M vs. OBIO: $148.38M
CRIS [@Biotechnology] is valued at $21M. OBIO’s [@Biotechnology] market capitalization is $148.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CRIS is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 4 TA indicator(s) are bullish while OBIO’s TA Score has 4 bullish TA indicator(s).

  • CRIS’s TA Score: 4 bullish, 3 bearish.
  • OBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than OBIO.

Price Growth

CRIS (@Biotechnology) experienced а +0.60% price change this week, while OBIO (@Biotechnology) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($148M) has a higher market cap than CRIS($21M). OBIO YTD gains are higher at: -31.250 vs. CRIS (-45.098). CRIS has higher annual earnings (EBITDA): -36.02M vs. OBIO (-70.94M). OBIO has more cash in the bank: 33.9M vs. CRIS (10.1M). CRIS has less debt than OBIO: CRIS (2.31M) vs OBIO (16.4M). CRIS has higher revenues than OBIO: CRIS (11.4M) vs OBIO (2.94M).
CRISOBIOCRIS / OBIO
Capitalization21M148M14%
EBITDA-36.02M-70.94M51%
Gain YTD-45.098-31.250144%
P/E RatioN/AN/A-
Revenue11.4M2.94M387%
Total Cash10.1M33.9M30%
Total Debt2.31M16.4M14%
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRISOBIO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 2 days ago
62%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNCZF11.75N/A
N/A
Banco BPM Societa Per Azioni
RWCB24.38N/A
N/A
Redwood Capital Bancorp (CA)
BFLBF107.60N/A
N/A
Bilfinger SE
VHIBF8.45-0.03
-0.35%
VITALHUB CORP
APTOF1.18-0.04
-3.48%
Aptose Biosciences. Inc.

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XBIT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XBIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+0.36%
XBIT - OBIO
40%
Loosely correlated
-2.01%
ADVM - OBIO
39%
Loosely correlated
+11.04%
OCUL - OBIO
38%
Loosely correlated
+7.09%
RXRX - OBIO
38%
Loosely correlated
+1.99%
ATNM - OBIO
38%
Loosely correlated
-6.51%
More